222 related articles for article (PubMed ID: 23287700)
61. Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.
Järbe TU; LeMay BJ; Halikhedkar A; Wood J; Vadivel SK; Zvonok A; Makriyannis A
Psychopharmacology (Berl); 2014 Feb; 231(3):489-500. PubMed ID: 24005529
[TBL] [Abstract][Full Text] [Related]
62. Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart.
Krylatov AV; Maslov LN; Lasukova OV; Pertwee RG
Bull Exp Biol Med; 2005 May; 139(5):558-61. PubMed ID: 16224548
[TBL] [Abstract][Full Text] [Related]
63. Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine.
Coutts AA; Brewster N; Ingram T; Razdan RK; Pertwee RG
Br J Pharmacol; 2000 Feb; 129(4):645-52. PubMed ID: 10683188
[TBL] [Abstract][Full Text] [Related]
64. Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).
van Diepen H; Schlicker E; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2008 Oct; 378(4):345-69. PubMed ID: 18654765
[TBL] [Abstract][Full Text] [Related]
65. Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.
Scherma M; Fattore L; Satta V; Businco F; Pigliacampo B; Goldberg SR; Dessi C; Fratta W; Fadda P
Br J Pharmacol; 2013 Jun; 169(4):820-33. PubMed ID: 23072421
[TBL] [Abstract][Full Text] [Related]
66. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
Grey J; Terry P; Higgs S
Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
[TBL] [Abstract][Full Text] [Related]
67. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
Duncan M; Kendall DA; Ralevic V
J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450
[TBL] [Abstract][Full Text] [Related]
68. Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210.
Serrano A; Vadas E; Ferrer B; Bilbao A; Granado N; Suárez J; Pavon FJ; Moratalla R; Rodríguez de Fonseca F
Psychopharmacology (Berl); 2021 Feb; 238(2):551-557. PubMed ID: 33410990
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors.
Zádor F; Otvös F; Benyhe S; Zimmer A; Páldy E
Neurochem Int; 2012 Aug; 61(3):378-88. PubMed ID: 22613132
[TBL] [Abstract][Full Text] [Related]
70. Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.
Gamble-George JC; Conger JR; Hartley ND; Gupta P; Sumislawski JJ; Patel S
Psychopharmacology (Berl); 2013 Aug; 228(3):401-9. PubMed ID: 23483200
[TBL] [Abstract][Full Text] [Related]
71. Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys.
Schulze DR; Carroll FI; McMahon LR
Psychopharmacology (Berl); 2012 Aug; 222(3):425-38. PubMed ID: 22374253
[TBL] [Abstract][Full Text] [Related]
72. Tolerance and cross-tolerance to cannabinoids in mice: schedule-controlled responding and hypothermia.
Singh H; Schulze DR; McMahon LR
Psychopharmacology (Berl); 2011 Jun; 215(4):665-75. PubMed ID: 21246187
[TBL] [Abstract][Full Text] [Related]
73. Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices.
Mendiguren A; Pineda J
Br J Pharmacol; 2009 Nov; 158(6):1579-87. PubMed ID: 19845674
[TBL] [Abstract][Full Text] [Related]
74. Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans.
Beaumont H; Jensen J; Carlsson A; Ruth M; Lehmann A; Boeckxstaens G
Br J Pharmacol; 2009 Jan; 156(1):153-62. PubMed ID: 19068079
[TBL] [Abstract][Full Text] [Related]
75. CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
Schlosburg JE; O'Neal ST; Conrad DH; Lichtman AH
Psychopharmacology (Berl); 2011 Aug; 216(3):323-31. PubMed ID: 21340468
[TBL] [Abstract][Full Text] [Related]
76. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
77. Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.
Wiley JL; Matthew Walentiny D; Vann RE; Baskfield CY
Behav Pharmacol; 2011 Sep; 22(5-6):480-8. PubMed ID: 21712709
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
79. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.
Järbe TU; Lamb RJ; Liu Q; Makriyannis A
Eur J Pharmacol; 2003 Apr; 466(1-2):121-7. PubMed ID: 12679148
[TBL] [Abstract][Full Text] [Related]
80. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
Baldassano S; Serio R; Mule' F
Eur J Pharmacol; 2008 Mar; 582(1-3):132-8. PubMed ID: 18234188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
